• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[尿路上皮肿瘤患者的尿癌胚抗原。与疾病分期和染色体众数的相关性]

[Urinary carcinoembryonic antigen in patients with urothelial tumors. Correlations with the stage of the disease and the modal chromosome number].

作者信息

Lazăr C, Pop T, Dumitrache D, Mamulea O

出版信息

Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir. 1978 Sep-Oct;27(5):379-85.

PMID:740964
Abstract

The carcino-embrionary antigen was estimated in 26 patients without malignant diseases (15 with inguinal hernia and 11 with urinary lithiasis--all of them before surgery), and in 47 patients with urothelial tumors. The direct radioimmune technique was used (a commercial kit from France /CEA IRE SORIN/) applied to isolated samples of sterile urine obtained at 12 hours. It was noted that:--patients without urologic disturbances had values under 1.5 micrograms in 12 hours in 93.4% of the cases;--in 44% of patients with non-malignant urological diseases (urinary lithiasis) the antigen values ranged between 1.5 and 3.0 micrograms in 12 hours;--patients with urothelial tumors had high values of the urinary carcinoembrionary antigen, in the range between 1.92 and 162.5 micrograms;--concentration of the urinary carcino-embionary antigen increases with the stage of the disease, with tumor polyploidia and in tumors with a high degree of anaplasia;--10--14 days after the removal of the tumor the values of the carcino-embrionary antigen show a significant decrease, even after total cystectomy but with cutaneous uretherostomy.

摘要

对26例无恶性疾病的患者(15例腹股沟疝患者和11例尿路结石患者——均在手术前)以及47例尿路上皮肿瘤患者的癌胚抗原进行了评估。采用直接放射免疫技术(使用法国的一种商用试剂盒/CEA IRE SORIN/),应用于12小时采集的无菌尿液分离样本。结果发现:——无泌尿系统疾病的患者93.4%在12小时内癌胚抗原值低于1.5微克;——44%患有非恶性泌尿系统疾病(尿路结石)的患者在12小时内抗原值在1.5至3.0微克之间;——尿路上皮肿瘤患者尿癌胚抗原值较高,在1.92至162.5微克之间;——尿癌胚抗原浓度随疾病分期、肿瘤多倍体情况以及间变程度高的肿瘤而增加;——肿瘤切除后10至14天,癌胚抗原值显著下降,即使在全膀胱切除并做皮肤输尿管造口术后也是如此。

相似文献

1
[Urinary carcinoembryonic antigen in patients with urothelial tumors. Correlations with the stage of the disease and the modal chromosome number].[尿路上皮肿瘤患者的尿癌胚抗原。与疾病分期和染色体众数的相关性]
Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir. 1978 Sep-Oct;27(5):379-85.
2
[Levels of carcinoembryonic antigen and alpha fetoproteins in urine of of workers at the Bydgoszcz industrial works "Pasamon"].比得哥什“帕萨蒙”工业工厂工人尿液中癌胚抗原和甲胎蛋白水平
Med Pr. 1993;44(3):255-9.
3
[Assessment of urinary ferritin, CEA and beta 2-MG determinations in patients with urinary tract malignancies].[尿路恶性肿瘤患者尿铁蛋白、癌胚抗原及β2微球蛋白检测的评估]
Hinyokika Kiyo. 1983 Feb;29(2):131-9.
4
[Clinical studies on the measurement of urinary tissue polypeptide antigen (TPA) levels using Prolifigen TPA kit "Daiichi"-II in urothelial cancers].使用第一制药TPA试剂盒“Daiichi”-II检测尿路上皮癌患者尿组织多肽抗原(TPA)水平的临床研究
Hinyokika Kiyo. 1988 Dec;34(12):2101-10.
5
Diagnostic value of urine cytology and urine carcinoembryonic antigen (CEA) level in the distinction between bladder cancer and urinary tract infection.尿细胞学检查及尿癌胚抗原(CEA)水平在鉴别膀胱癌与尿路感染中的诊断价值。
Int J Occup Med Environ Health. 1995;8(2):103-8.
6
Over expression of CD44V8-10 in urinary exfoliated cells as an independent prognostic predictor in patients with urothelial cancer.尿脱落细胞中CD44V8-10的过表达作为尿路上皮癌患者的独立预后预测指标。
J Urol. 2002 Mar;167(3):1282-7.
7
Upper tract urothelial tumors. Diagnostic efficiency of radiology and urinary cytology.上尿路尿路上皮肿瘤。放射学与尿液细胞学的诊断效能
Eur Urol. 1982;8(3):145-7.
8
[Determination of carcinoembryonic antigen in urine and in gastric secretions].[尿液及胃分泌物中癌胚抗原的测定]
Minerva Med. 1983 Nov 16;74(44):2671-5.
9
[Urinary tumor marker for urothelial cancer].
Gan To Kagaku Ryoho. 2001 Nov;28(12):1933-7.
10
Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.结肠腺癌患者血清、尿液和组织中的组织蛋白酶D与癌胚抗原
Hepatogastroenterology. 2008 Mar-Apr;55(82-83):388-93.